Related Experiment Video
Updated: Jun 26, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Addressing the challenges for improving long-term outcomes in renal transplantation
1Centre for Transplant and Renal Research, Westmead Millennium Institute, University of Sydney, Westmead Hospital, Westmead NSW 2145, Australia. jeremy_chapman@wsahs.nsw.gov.au
Renal transplant success remains limited by chronic nephropathy, cardiac disease, cancer, and infection. Current immunosuppression strategies balance graft survival with drug toxicity, highlighting the need for new approaches.
Area of Science:
- Nephrology
- Transplant Immunology
- Pharmacology
Background:
- Renal transplant recipients face graft loss from chronic allograft nephropathy and mortality from cardiac disease, malignancy, and infection.
- While acute rejection was the primary challenge previously, long-term success rates have stagnated despite improved short-term outcomes.
- Current immunosuppressive protocols aim to prevent acute rejection but carry significant toxicities and infection risks.
Purpose of the Study:
- To address the persistent challenges in renal transplantation, focusing on chronic allograft nephropathy, cardiac disease, malignancy, and infection.
- To re-evaluate immunosuppressive strategies balancing the need for graft protection with minimizing long-term drug toxicity.
- To identify early indicators for predicting long-term renal transplant success.
Main Methods:
- Review of current immunosuppressive protocols, including induction strategies and maintenance therapies.
- Analysis of the trade-offs between immunosuppressive efficacy and drug-related toxicities (nephrotoxicity, cardiovascular, malignancy).
- Exploration of long-term strategies such as calcineurin inhibitor dose reduction/elimination and mammalian target of rapamycin inhibitor incorporation.
Main Results:
- Despite advancements, long-term renal transplant success rates have not improved significantly.
- Standard immunosuppression involves biological agents, calcineurin inhibitors, antiproliferatives, and corticosteroids, with varying long-term management approaches.
- The lack of a dominant protocol underscores the need for better early indicators of long-term outcomes.
Conclusions:
- Future renal transplant programs must prioritize managing chronic allograft nephropathy, cardiac disease, malignancy, and infection.
- Optimizing immunosuppression requires balancing efficacy with the avoidance of long-term toxicities and infection risks.
- Further research is needed to establish reliable early indicators for predicting long-term renal transplant success and guide personalized treatment strategies.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Chronic Kidney Disease III: Interprofessional Care

